Marshall Wace, LLP Angiodynamics Inc Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Angiodynamics Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 33,226 shares of ANGO stock, worth $309,998. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,226

Previous 67,457 50.74%

Holding current value

$309,998

Previous $408,000 36.76%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.51 - $7.84 $188,612 - $268,371	-34,231 Reduced 50.74%	33,226 $258,000
Q2 2024 Aug 14, 2024	SELL	$5.65 - $7.03 $1.23 Million - $1.54 Million	-218,500 Reduced 76.41%	67,457 $408,000
Q1 2024 May 15, 2024	BUY	$5.27 - $8.03 $1.41 Million - $2.15 Million	267,357 Added 1437.4%	285,957 $1.68 Million
Q4 2023 Feb 14, 2024	SELL	$6.17 - $8.04 $726,585 - $946,798	-117,761 Reduced 86.36%	18,600 $145,000
Q3 2023 Nov 14, 2023	BUY	$7.02 - $10.32 $957,254 - $1.41 Million	136,361 New	136,361 $996,000
Q1 2023 May 15, 2023	SELL	$9.1 - $15.48 $393,766 - $669,835	-43,271 Reduced 60.13%	28,694 $296,000
Q4 2022 Feb 14, 2023	BUY	$12.06 - $21.55 $867,897 - $1.55 Million	71,965 New	71,965 $990,000
Q2 2020 Aug 13, 2020	SELL	$9.05 - $12.01 $307,446 - $408,003	-33,972 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$8.33 - $16.9 $2.25 Million - $4.56 Million	-270,114 Reduced 88.83%	33,972 $354,000
Q4 2019 Feb 14, 2020	BUY	$14.23 - $18.16 $2.62 Million - $3.34 Million	184,127 Added 153.49%	304,086 $4.87 Million
Q3 2019 Nov 14, 2019	BUY	$17.78 - $21.89 $1.85 Million - $2.28 Million	104,258 Added 664.02%	119,959 $2.21 Million
Q2 2019 Aug 14, 2019	BUY	$18.78 - $25.01 $294,864 - $392,682	15,701 New	15,701 $310,000

Others Institutions Holding ANGO

# of Institutions

141

Shares Held

32.8M

Call Options Held

8.9K

Put Options Held

View Full List

About ANGIODYNAMICS INC

Ticker ANGO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 39,107,800
Market Cap $365M
Description
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation syst...

More about ANGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Angiodynamics Inc Transaction History